Spinraza OverviewNusinersen, marketed as Spinraza, is a medication used in treating spinal muscular atrophy (SMA), a rare neuromuscular disorder. In December 2016, it became the first approved drug used in treating this disorder. Nusinersen cost US$750,000 in the first year and US$375,000 annually after that in the United States as of 2019. Nusinersen has orphan drug designation in the United States and the European Union.[7&a...
Read more Spinraza Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Nusinersen
Recent Spinraza Forums:Be the first to start a discussion about this drug.
Possible Dosages for this and Related Drugs:
- Injection: 2.4mg/ml
- Solution: 12mg/5ml (2.4mg/ml)
NDC Database Records for Spinraza: (1 result)Sorted by National Drug Code
- 64406-058 Spinraza 2.4 mg/ml Intrathecal Injection, Solution by Biogen